Author:
Rendina E. A.,Venuta F.,Giacomo T.,MariaCiccone Anna,Coloni G. F.
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Albain KS, Crowley JJ, Le Blanc M, et al.: Survival determinants in extensive-stage non-small cell lung cancer: the Southwest Oncology Group experience. J Clin Oncol 1991; 9: 1618–1626.
2. Albain KS, Rusch VW, Crowley JJ, et al: Concurrent Cisplatin/Etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small cell lung cancer: mature results of Southwest Oncology Group Phase II study 8805. J Clin Oncol 1995; 13: 1880–1892.
3. Bonomi P, Kim K, Chang A, et al: Phase III trial comparing etoposide (E), cisplatin (C) versus taxol (T) with cisplatin-G-CSF (G) versus Taxol-cisplatin in advanced non-small cell lung cancer. An Eastern Cooperative Group (ECOG) trial. Proc Am Soc Clin Oncol (abstr) 1996; 15: 382.
4. Carney DN: Management (chemotherapy/best supportive care) of advancedstage non-small cell lung cancer. Semin Oncol 1995; 22 (Suppl. 9): 58.
5. Dartevelle P, Chapelier A, Navajas M, et al.: Replacement of the superior vena cava with polytetrafluoroethylene grafts combined with resection of mediastinalpulmonary malignant tumors. Report of thirteen cases. J Thorac Cardiovasc Surg 1987; 94: 361–366.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Editorial;European Surgery;1999-09